These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2839096)

  • 1. [Specificity of an elevated level of descarboxy-prothrombin in hepatocarcinoma after injection of vitamin K].
    Soulier JP; Lefrère JJ; Gozin D
    Ann Gastroenterol Hepatol (Paris); 1988; 24(2):77-9. PubMed ID: 2839096
    [No Abstract]   [Full Text] [Related]  

  • 2. [Assay of decarboxy-prothrombin: its value in the diagnosis of hepatocellular carcinoma].
    Soulier JP; Lefrère JJ; Gozin D
    Ann Med Interne (Paris); 1988; 139(1):7-11. PubMed ID: 2834988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal prothrombin (PIVKA-II) and hepatocellular carcinoma.
    Okuda H; Nakanish T; Furukawa M; Yamagata H; Obata H
    Trop Gastroenterol; 1991; 12(2):59-66. PubMed ID: 1719681
    [No Abstract]   [Full Text] [Related]  

  • 4. Des-gamma-carboxyprothrombin in hepatocellular carcinoma after vitamin K1 injection.
    Buffet C; Bismuth E; Hagege H; Etienne JP
    Dig Dis Sci; 1989 Jun; 34(6):963-4. PubMed ID: 2470560
    [No Abstract]   [Full Text] [Related]  

  • 5. Assay of des-gamma-carboxyprothrombin using staphylocoagulase. Application to the diagnosis of cellular hepatocarcinoma.
    Soulier JP; Gozin D; Lefrère JJ
    Haematologia (Budap); 1986; 19(1):3-12. PubMed ID: 2424813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of immunoreactive prothrombin, des-gamma-carboxy prothrombin, and vitamin K in human liver tissues: overproduction of immunoreactive prothrombin in hepatocellular carcinoma.
    Ono M; Ohta H; Ohhira M; Sekiya C; Namiki M
    Am J Gastroenterol; 1990 Sep; 85(9):1149-54. PubMed ID: 1697141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of different des-gamma-carboxyproteins in hepatocellular carcinoma.
    Lefrère JJ; Van Dreden P; Samama M
    Thromb Haemost; 1987 Dec; 58(4):1092. PubMed ID: 2832965
    [No Abstract]   [Full Text] [Related]  

  • 8. The growth inhibitory effects of vitamins K and their actions on gene expression.
    Wang Z; Wang M; Finn F; Carr BI
    Hepatology; 1995 Sep; 22(3):876-82. PubMed ID: 7657295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Decarboxyprothrombin: importance in the diagnosis of hepatocellular carcinoma].
    Bon C; Brillard B; Gelineau MC; Mailliavin A; Trépo C; Pichot J
    Ann Biol Clin (Paris); 1998; 56(2):175-81. PubMed ID: 9754243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of simultaneous determination of alpha-fetoprotein and des-gamma-carboxy prothrombin in hepatocellular carcinoma.
    Nakao A; Taniguchi K; Inoue S; Harada A; Nonami T; Watanabe K; Takagi H
    Semin Surg Oncol; 1996; 12(3):160-3. PubMed ID: 8727604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin K-dependent proteins and hepatocellular carcinoma.
    Okuda H; Nakanishi T; Furukawa M; Obata H
    J Gastroenterol Hepatol; 1991; 6(4):392-9. PubMed ID: 1655099
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
    Soga K; Watanabe T; Aikawa K; Toshima M; Shibasaki K; Aoyagi Y
    Hepatogastroenterology; 1998; 45(23):1737-41. PubMed ID: 9840138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical application of a new monoclonal antibody (19B7) against PIVKA-II in the diagnosis of hepatocellular carcinoma and pancreatobiliary malignancies.
    Nakao A; Taniguchi K; Inoue S; Takeda S; Harada A; Nonami T; Watanabe K; Takagi H
    Am J Gastroenterol; 1997 Jun; 92(6):1031-4. PubMed ID: 9177525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biological markers of hepatocellular carcinoma].
    Arfaoui D; Elloumi H; Ajmi S
    Tunis Med; 2004 Apr; 82(4):329-34. PubMed ID: 15453027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acarboxy prothrombin (PIVKA II) as a tumour marker for hepatocellular carcinoma and other liver diseases.
    Mohamedein A; Yousif-Kadaru AG; Ahmed SA; Saida H; Zaki ZA; Eldin ; Fedail SS
    East Afr Med J; 1995 Sep; 72(9):584-7. PubMed ID: 7498046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
    Aoyagi Y; Oguro M; Yanagi M; Mita Y; Suda T; Suzuki Y; Hata K; Ichii K; Asakura H
    Cancer; 1996 May; 77(9):1781-6. PubMed ID: 8646674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies of vitamin K sensitivity of PIVKA-II in patients with hepatocellular carcinoma].
    Furukawa M; Nakanishi T; Okuda H; Obata H
    Nihon Shokakibyo Gakkai Zasshi; 1988 Dec; 85(12):2583-9. PubMed ID: 2854170
    [No Abstract]   [Full Text] [Related]  

  • 18. [Molecular markers for early diagnosis of hepatocellular carcinoma].
    Yao DF
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):492. PubMed ID: 15329213
    [No Abstract]   [Full Text] [Related]  

  • 19. The des-gamma-carboxyprothrombin for the diagnosis of hepatocellular carcinoma.
    Brunello F; Marcarino C; Pasquero P; Gastaldi P; Gonella S; Martini S; Calcamuggi G; Emanuelli G
    Ital J Gastroenterol; 1993 Jan; 25(1):9-12. PubMed ID: 7679014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated plasma osteopontin levels in patients with hepatocellular carcinoma.
    Kim J; Ki SS; Lee SD; Han CJ; Kim YC; Park SH; Cho SY; Hong YJ; Park HY; Lee M; Jung HH; Lee KH; Jeong SH
    Am J Gastroenterol; 2006 Sep; 101(9):2051-9. PubMed ID: 16848813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.